Form 4: Allison Transmission Executive Acquires Dividend Equivalent Rights
SEC Form 4 Filing
Thomas Eifert, VP at Allison Transmission, reports acquisition of dividend equivalent rights related to previously awarded restricted stock units.
Summary
- On March 14, 2025, Thomas Eifert, VP of Quality Plan & Prog Mgmt at Allison Transmission Holdings Inc, acquired 9 dividend equivalent rights.
- These rights are associated with previously awarded restricted stock units (RSUs) and will vest proportionally with those RSUs.
- Each dividend equivalent right represents the economic equivalent of one share of Allison Transmission Holdings, Inc. common stock.
- Following the transaction, Mr. Eifert directly owns 53 dividend equivalent rights.
- The transaction was reported on March 18, 2025.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing. It doesn't convey any positive or negative sentiment about the company's performance or prospects.
Industry Context
This Form 4 filing is a routine disclosure related to insider transactions and provides transparency into the holdings of company executives. It's a standard practice for publicly traded companies.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders.
- It provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 03/14/2025 | Date of transaction: Acquisition of dividend equivalent rights. |
| 03/18/2025 | Date of Form 4 filing. |
Keywords
dividend equivalent rights, Allison Transmission, Form 4, insider trading, Thomas Eifert, ALSN, RSUs, securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.